Status:
NOT_YET_RECRUITING
Chinese Medicine in Treating Insomnia
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Insomnia Chronic
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This is a randomized, double-blinded, placebo-controlled clinical trial. Eligible participants will randomized into either treatment group (CM granules) or placebo group (placebo granules) for 6 weeks...
Detailed Description
Insomnia is one of the most general health concerns in the society. It is generally defined as a self-reported sleep disorder problem of the patient, characterized by difficulty in falling asleep, or ...
Eligibility Criteria
Inclusion
- Age from 18 to 65 years;
- Eligible for the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, criteria for insomnia disorder. The criteria include having difficulties in falling asleep, difficulties in staying asleep, or early morning awakening with clinically significant consequences for daily life for at least 3 nights per week for at least 6 months;
- Insomnia Severity Index (ISI) total score of at least 8 indicating insomnia at the clinical level;
- Diagnosed to be Yin deficiency-induced internal heat pattern according to traditional Chinese Medicine (TCM) theory;
- Able to complete questionnaires and take medications as scheduled; and
- Voluntary written consent.
Exclusion
- Known nervous system disease (eg, stroke, Parkinson's Disease);
- Known mental disorders (eg, depression or anxiety) or HADS score 11 or above in any either item;
- Known sleeping related diseases (eg. sleep apnea, nocturnal myoclonus, restless legs, severe nocturnal enuresis or narcolepsy) that may affect the sleeping quality;
- Known pharmacologically induced insomnia;
- With symptoms that significantly disturb sleep such as pain, fever, diarrhea, frequent micturition, and cough;
- Know treatment to comorbid sleep disorders, such as sleep apnea or narcolepsy;
- Work on shift or on night shift;
- Concomitant pharmacological treatment or herbal medicines for insomnia within the past month;
- Known severe medical conditions, such as cardiovascular, liver, kidney or hematopoietic system disease, diabetes mellitus, cancers, cerebrovascular diseases;
- Impaired hematological profile and liver / renal function exceeds the upper limit of the reference value by 2 times;
- Known alcohol and / or drug abuse;
- Known allergic history to any Chinese herbal medicines;
- Diagnosed to be deficiency of spleen according to TCM theory;
- Any contraindications for taking Chinese medicines in the opinion of the investigators;
- Know pregnant or lactating; and
- Involved in other interventional clinical studies at the same time.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06511011
Start Date
September 1 2024
End Date
August 1 2026
Last Update
July 25 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.